Eprotirome: Karo Bio and Alkem collaborate


Karo and Alkem collaborate to develop Eprotirome. Karo bio has granted license to Alkem to commercialize in India and certail countires. Alkem will participate in Karo Bio’s phase III programme for eprotirome by conducting a pivotal clinical study on eprotirome in India.

Eprotirome seems to be protected by 206517 (IN/PCT/2002/00888/MUM) and its pending divisional (139/MUMNP/2007) protects combination with other drugs. This patent is assigned to BMS. Karo Bio has another new drug research collaboration with Zydus too.

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s